Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nolvadex Dosing for Casodex-Induced Gynecomastia
NCT00233610Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2003
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tamoxifen in gynecomastia and mastalgia (2 arms), sponsored by AstraZeneca. Primary endpoint: Incidence of Gynecomastia and Breast pain. Started Dec 2003; status: completed.
02
Drugs
tamoxifen
03
Conditions
gynecomastiamastalgia
Beyond the preview
Go deeper on NCT00233610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00233610.